RA
AVNR

Royce & Associates’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Royce & Associates’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-405,100
Closed -$6.87M – 1370
2014
Q4 		$6.87M Sell
405,100
-884,000
-69% -$12.4M 0.02% 715
2014
Q3 		$15.4M Buy
+1,289,100
New +$8.8M 0.05% 440

Royce & Associates's AVNR Position: Q1 2015 in Review

Royce & Associates sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 405,100 shares — an estimated $6.87M sold.

Royce & Associates first reported a position in AVNR in Q3 2014 and held it in 2 quarters. The position peaked at $15.4M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Royce & Associates reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Royce & Associates sold 405,100 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $6.87M.
  • Royce & Associates first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2014 and held it in 2 quarters.
  • Royce & Associates's AVANIR PHARMACEUTICALS, INC CL A position peaked at $15.4M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Royce & Associates's 13F filing for Q1 2015, filed 13 May 2015.